Sideroblastic anaemia.
D000624:5-Aminolevulinate Synthetase / Q000378:metabolism; D000328:Adult; D000756:Anemia, Sideroblastic / Q000097:blood* / Q000139:chemically induced / Q000151:congenital; D001803:Blood Transfusion; D001853:Bone Marrow / Q000201:enzymology; D002701:Chloramphenicol / Q000009:adverse effects; D003676:Deferoxamine / Q000627:therapeutic use; D004900:Erythroblasts / Q000378:metabolism; D000431:Ethanol / Q000009:adverse effects; D005260:Female; D005294:Ferrochelatase / Q000378:metabolism; D006418:Heme / Q000096:biosynthesis; D006432:Hemochromatosis / Q000097:blood; D006801:Humans; D000090463:Iron Deficiencies; D007538:Isoniazid / Q000009:adverse effects; D008297:Male; D008558:Melphalan / Q000009:adverse effects; D009196:Myeloproliferative Disorders / Q000097:blood; D011736:Pyridoxine / Q000378:metabolism / Q000627:therapeutic use; D013577:Syndrome
D000431:Ethanol; D006418:Heme; D002701:Chloramphenicol; D000624:5-Aminolevulinate Synthetase; D005294:Ferrochelatase; D003676:Deferoxamine; D011736:Pyridoxine; D008558:Melphalan; D007538:Isoniazid